|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - $180.17 /
+12.65 (+7.55%) - 09/06/21
- Fly Intel: Top five weekend stock stories
- 05/19/21
- Acceleron gives interim results of Pulsar trial of sotatercept in PAH patients
- 05/19/21
- Acceleron presents SPECTRA Phase 2 Trial data on sotatercept in PAH
- 05/12/21
- Acceleron to present on Reblozyl at EHA2021
- 09/21/21
- Velodyne Lidar enters multi-year supply agreement with Topodrone
- 08/31/21
- Velodyne Lidar and MOV.AI announce collaboration
- 08/25/21
- Velodyne Lidar announces multi-year sales agreement with Renu Robotics
- 08/24/21
- Velodyne Lidar responds to David Hall's open letter to the board
- 08/23/21
- Vir Biotechnology announces first marketing authorization for sotrovimab
- 07/30/21
- GSK Covid injection granted Interim Order authorization in Canada
- 07/28/21
- GSK, Vir Biotechnology announce joint procurement pact with EC for sotrovimab
- 07/08/21
- Cerence, Visteon to integrate conversational AI in SmartCore product
- 06/22/21
- Visteon, ECARX, Qualcomm debut intelligent cockpit solution
- $792.36 /
+17.74 (+2.29%) - 09/27/21
- Tesla using untrained drivers 'as testers for unproven system,' says Blumenthal
- 09/24/21
- VW CEO says new Tesla factory in Germany will increase competition
- 09/23/21
- Chip shortages will cost auto industry $210B in 2021, AlixPartners forecasts
- 07/07/21
- SeaSpine receives FDA clearance for 7D Percutaneous Spine Module
- 04/19/21
- SeaSpine announces commercial launch of WaveForm 3D system
- 04/15/21
- SeaSpine falls 5% to $19.89 after common stock offering
- 09/01/21
- Fuzzy Panda Research short Workhorse on 'active SEC investigation, fake orders'
- 08/26/21
- Lordstown Motors appoints Daniel Ninivaggi as Chief Executive Officer
- 08/20/21
- Lordstown Motors announces demonstration of Lordstown Endurance
- 08/16/21
- Lordstown Motors appoints Eric Purcell as VP, global quality
- 09/27/21
- Red Cat subsidiary receives five-year contract with NASA
- 08/16/21
- Red Cat receives purchase order from Drone Nerds
- 07/13/21
- Red Cat to acquire Teal Drones in an all-stock transaction
- 06/09/21
- Red Cat reorganizing drone business into Enterprise and Consumer segments
- 09/27/21
- Polestar to go public via merger with Gores Guggenheim
- 09/27/21
- Prime Mining provides update on exploration during Q1
- 09/27/21
- Prime Mining appoints Edie Hofmeister to board, Scott Smith as VP, exploration
- 09/08/21
- Prime Mining reports Phase 1 dril results from Los Reyes project
- 09/24/21
- BetMGM signs MMA journalist Ariel Helwani as brand ambassador
- 09/21/21
- MGM to engage with Entain and DraftKings, 'as appropriate,' on possible bid
- 09/14/21
- Veoneer receives updated acquisition proposal from Qualcomm for $37.00 per share
- 09/13/21
- Qualcomm slips 5% to under $137 after Veoneer says Magna deal still in effect
- 09/13/21
- Veoneer says merger pact with Magna remains in full force and effect
- 09/13/21
- Veoneer confirms receipt of $37 per share offer from Qualcomm
- 09/22/21
- Lear, Hu Lane Associate enter joint venture in Yangzhou
- 08/12/21
- Lear raises quarterly cash dividend to 50c from 25c per share
- 07/22/21
- Lear names Alicia Davis as Chief Strategy Officer
- 06/16/21
- Lear, IMS Connector Systems partner on high speed ethernet solutions
KEYS Keysight Technologies - 09/27/21
- Keysight Technologies, NCUOSC collaborate for GaN, SiC applications
- 07/06/21
- Keysight says 5G 'industry-first milestone' reached in partnership with Qualcomm
- 05/25/21
- Keysight Technologies acquires Quantum Benchmark, terms not disclsosed
- 05/17/21
- Keysight Technologies commits to net zero emissions by end of 2040
- 09/27/21
- JinkoSolar to invest $500M to build monocrystalline ingot, wafer facility
- 09/15/21
- JinkoSolar rises 6.3%
- 09/02/21
- JinkoSolar subsidiary sign coperation framework agreement with CATL
- 08/18/21
- JinkoSolar subsidiary signs long-term polysilicon supply agreement with Wacker
INVZ Innoviz Technologies - 08/10/21
- Innoviz Technologies forms partnership with Curium
- 08/09/21
- Innoviz Technologies and Whale Dynamic announce collaboration
- 06/08/21
- Innoviz Technologies and Cron AI announce new partnership
- 05/18/21
- Innoviz Technologies announces partnership with SensaVision
- 09/27/21
- iBio continues to develop IBIO-400 Classical Swine Fever Vaccine
- 09/27/21
- iBio discontinues development of discovery-stage ACE2-Fc project
- 09/27/21
- iBio sees sequential decline in revenue during 1H22 vs. 2H21
- 09/27/21
- iBio expects cash to fund operations through 1Q23
- 09/23/21
- Humana signs in-network agreement with Kelsey-Seybold Clinic
- 09/17/21
- Centene up 2% after Gordon Haskett discusses Humana trip to St. Louis
- 07/08/21
- Humana hiring up to 200 seasonal positions in San Antonio
- 07/08/21
- Humana, Montefiore Health System sign multiyear coverage agreement
- 09/27/21
- GSK, Vir receive Japanese approval for monoclonal antibody for COVID treatment
- 09/17/21
- GSK receives CHMP positive opinions for Nucala in three additional diseases
- 09/09/21
- HHS Secretary releases proposal to lower prescription drug costs
- 09/09/21
- Alector doses first patient in Phase 2 study of AL001 in ALS
- $2,827.67 /
-26.03 (-0.91%) - 09/27/21
- Google selects Similarweb to power new 'export readiness' service
- 09/23/21
- Google debuts new accessibility features to make Android user-friendly for all
- 09/22/21
- Google enhances ad disclosures with new advertiser pages
- 08/04/21
- Gentex approves additional share repurchase authorization of 25M shares
- 05/20/21
- Gentex ships Bluetooth-enabled mirrors to Volkswagen
- 09/23/21
- GM invests $300M in autonomous driving technology company Momenta
- 09/22/21
- Honeywell's Quality Control System selected by Ultium for Lordstown plant
- 09/22/21
- GM to offer OnStar emergency service at home via Amazon partnership
- 09/27/21
- Polestar to go public via merger with Gores Guggenheim
- 09/26/21
- Fly Intel: Top five weekend stock stories
- 05/27/21
- Gores Guggenheim discloses Nasdaq notice regarding delayed quarterly report
- $351.45 /
-1.685 (-0.48%) - 09/27/21
- 'Resident Evil 4' in VR launches for Oculus Quest 2 on October 21
- 09/27/21
- Facebook creates $50M fund to build metaverse products 'responsibly'
- 09/27/21
- UK's CMA announces clearance of Facebook's acquisition of Kustomer
- 09/27/21
- Instagram pausing work on 'Instagram Kids'
- 07/28/21
- Deutsche Bank reaffirms 2022 ratio targets
- 06/21/21
- Deutsche Bank, Fiserv enter payment acceptance joint venture in Germany
- 04/28/21
- Deutsche Bank rises 9.3%
- 04/28/21
- Deutsche Bank CEO confident on reaching 2022 targets
- 08/13/21
- Credit Suisse hires former UBS executive to head risk committee
- 07/29/21
- Credit Suisse publishes report on independent investigation into Archegos
- 07/29/21
- Credit Suisse: CSAM focus is returning cash to investors, maximizing recoveries
- 07/29/21
- Credit Suisse reports outcome of independent investigation into Archegos matter
CAPR Capricor Therapeutics - 09/24/21
- Capricor Therapeutics announce 'positive' final data from Phase 2 HOPE-2 trial
- 09/02/21
- Capricor Therapeutics to present final data from HOPE-2 trial of CAP-1002
- 08/04/21
- Capricor Therapeutics announces joint publication with US Army Institute
- 07/27/21
- Capricor Therapeutics appoints Karimah Es Sabar to its board of directors
- 09/27/21
- Blackstone to sell The Cosmopolitan of Las Vegas for $5.65B
- 09/27/21
- MGM Resorts to acquire operations of The Cosmopolitan of Las Vegas for $1.625B
- 09/23/21
- Condor Hospitality to sell hotel portfolio for $305M, adopt plan of liquidation
- 09/17/21
- Blackstone appoints Frederic Kerrest as senior advisor
- 08/23/21
- BorgWarner secures minority stake in Enexor BioEnergy
- 08/16/21
- BorgWarner announces Series C equity investment in CelLink
- 08/04/21
- BorgWarner closes contracts to supply dual inverters to two Chinese OEMs
- 08/03/21
- BorgWarner enters partnership with ZEEKR Intelligent Technology Co.
- 09/22/21
- Biogen falls after STAT says just over 100 patients on Aduhelm as of Sept. 11
- 09/21/21
- Biogen to provide overview of pipeline, capabilities at R&D Day
- 09/20/21
- Biogen, Samsung Bioepis announce FDA approval of BYOOVIZ
- 09/17/21
- Biogen announces positive CHMP opinion for VUMERITY
- 09/27/21
- Vinco Ventures up 17% in pre-market trading at $7.42 per share
- 09/08/21
- Vinco Ventures jumps 19% in early trading after offering details of Zash merger
- 09/08/21
- Vinco Ventures announces 2021 annual proxy
- 09/01/21
- Vinco Ventures trading resumes
- 09/24/21
- Altice USA falls -8.4%
- 09/23/21
- Altice USA 'hopeful' Q4 will see positive net adds, normalized trends
- 09/23/21
- Altice USA sees negative Q3 Internet net adds of (20,000)-(15,000)
- 09/23/21
- Altice USA sees 'negative' Internet net adds in Q3
- 09/27/21
- Aspen Group director Douglas Kass buys 32K share of common stock
- 07/14/21
- Aspen Group appoints Joan Prince to board of directors
- 07/13/21
- Aspen Group names Matthew LaVay as CFO
- 05/18/21
- Aspen Group reports Q4 quarterly enrollments up 23% to 2,182 new students
ASLN Aslan Pharmaceuticals - 09/27/21
- Aslan Pharmaceuticals reports 'positive' results from Phase 1 study of ASLAN004
- 09/21/21
- Aslan Pharmaceuticals establishes Scientific Advisory Board
- 08/06/21
- Aslan Pharmaceuticals anticipated upcoming milestones
- 07/13/21
- Aslan Pharmaceuticals announces loan facility up to $45M
- 08/24/21
- Google unit Waymo debuts autonomous rides in San Francisco
- 08/19/21
- Luminar announces Munir Hafez joins company as CIO
- 04/28/21
- Amphenol announces new $2B open market stock repurchase plan
- 04/08/21
- Cara Therapeutics to replace MTS Systems in S&P 600 at open on 4/8
- 04/07/21
- Amphenol completes acquisition of MTS systems
- $3,372.13 /
-54.85 (-1.60%) - 09/27/21
- Amazon announces new capabilities for Amazon Connect
- 09/23/21
- Reservoir Media 'applauds' agreement between NMPA, Twitch
- 09/22/21
- Amazon Web Services to open data centers in New Zealand
- $173.84 /
-2.065 (-1.17%) - 09/27/21
- Airbnb announces 1B in guest arrivals at Host listings
- 09/20/21
- Airbnb CEO: Our model is very adaptable
- 09/13/21
- Airbnb says New York's 2309-2021 imposes expensive requirements
- 08/12/21
- Airbnb sees Q3 revenue the strongest quarterly revenue on record
- 09/23/21
- UnitedHealthcare to offer 'millions of members' free year of Apple Fitness+
- 09/22/21
- Epic CEO says 'Fortnite' to be blacklisted from Apple ecosystem
- 09/21/21
- Sirius XM launches new free channel with Marvel on Apple podcasts
- $351.45 /
-1.685 (-0.48%) - 09/24/21 BTIG
- Etsy price target raised to $238 from $215 at BTIG
- 09/22/21 Morgan Stanley
- Facebook blog post not signal of near-term ad revenue risk, says Morgan Stanley
- 09/22/21 BMO Capital
- Facebook guidance unchanged, not much new on technical side, says BMO Capital
- 09/22/21 Baird
- Facebook IDFA update largely consistent with industry checks, says Baird
- 09/13/21
- Fly Intel: Top five analyst upgrades
- 09/13/21 BMO Capital
- Carlyle Group upgraded to Outperform from Market Perform at BMO Capital
- 09/03/21 Evercore ISI
- Gates Industrial initiated with an Outperform at Evercore ISI
- 08/12/21 TD Securities
- WPT Industrial REIT downgraded to Hold from Buy at TD Securities
- 09/24/21 Credit Suisse
- As Macau locks down, Credit Suisse warns of downside risk to 2022 GGR estimates
- 09/22/21 Craig-Hallum
- Craig-Hallum says DraftKings deal outcome 'unanimously negative for competitors'
- 09/21/21 Jefferies
- Jefferies sees takeout value for Entain at least GBp 2,820 per share
- 09/14/21 Wells Fargo
- MGM Resorts initiated with an Overweight at Wells Fargo
- 09/20/21 UBS
- GlaxoSmithKline price target lowered to 1,460 GBp from 1,540 GBp at UBS
- 09/09/21 RBC Capital
- Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
- 08/26/21 UBS
- GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
- 08/20/21 JPMorgan
- GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
- 09/22/21
- Fly Intel: Top five analyst downgrades
- 09/22/21 Goldman Sachs
- Vir Biotechnology downgraded to Neutral from Buy at Goldman Sachs
- 06/03/21 Baird
- Vir Biotechnology assumed with a Neutral at Baird
- 05/27/21 Piper Sandler
- Xencorc royalty revenue streams growing, says Piper Sandler
- 09/27/21 Credit Suisse
- Apple iPhone 13 extended waits versus 12 cycle continue, says Credit Suisse
- 09/22/21 Tigress Financial
- Apple price target raised to $198 from $182 at Tigress Financial
- 09/21/21 BofA
- BofA says nationalist sentiment resurgence in China could hurt iPhone sales
- $792.36 /
+17.74 (+2.29%) - 09/23/21
- Fly Intel: Top five analyst initiations
- 09/23/21 Tudor Pickering
- Tudor Pickering starts 'fundamentally overvalued' Tesla at Sell
- 09/23/21 Tudor Pickering
- Tesla initiated with a Sell at Tudor Pickering
- 09/17/21 Morgan Stanley
- 520 mile EPA range 'an important milestone' for Lucid, says Morgan Stanley
- $180.17 /
+12.65 (+7.55%) - 09/27/21 RBC Capital
- Acceleron price target raised to $179 from $113 at RBC Capital
- 08/05/21 Piper Sandler
- Acceleron price target raised to $146 from $143 at Piper Sandler
- 07/19/21 Wolfe Research
- Acceleron assumed with an Outperform at Wolfe Research
- 06/24/21 Oppenheimer
- Acceleron price target raised to $160 from $141 at Oppenheimer
- 09/27/21 SVB Leerink
- SVB Leerink 'looking through the noise,' starts Humana at Outperform
- 09/27/21 SVB Leerink
- Humana initiated with an Outperform at SVB Leerink
- 09/24/21 Piper Sandler
- 1Life Healthcare price target lowered to $37 from $55.50 at Piper Sandler
- 09/09/21 Cowen
- Humana initiated with an Outperform at Cowen
- 09/27/21 Oppenheimer
- Prothena price target raised to $100 from $90 at Oppenheimer
- 09/24/21 JPMorgan
- Eli Lilly remains best positioned growth story in pharma, says JPMorgan
- 09/23/21 Mizuho
- Biogen sales reps banned by D.C. neurology practice, says Mizuho
- 09/23/21 Cowen
- CMS director telling states Aduhelm covered, restrictions can apply, says Cowen
- 09/17/21 JPMorgan
- Deutsche Bank price target raised to EUR 13.50 from EUR 13 at JPMorgan
- 08/13/21
- Fly Intel: Top five analyst upgrades
- 08/13/21 Keefe Bruyette
- Deutsche Bank upgraded to Market Perform from Underperform at Keefe Bruyette
- 07/29/21 Credit Suisse
- Deutsche Bank price target raised to EUR 10.50 from EUR 10 at Credit Suisse
- 09/17/21 JPMorgan
- Credit Suisse price target lowered to CHF 11.30 from CHF 11.60 at JPMorgan
- 08/12/21 Citi
- Credit Suisse removed from EMEA Focus List at Citi
- 07/30/21 Barclays
- Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays
- 07/30/21 JPMorgan
- Credit Suisse price target lowered to CHF 11.60 from CHF 11.70 at JPMorgan
- $2,827.67 /
-26.03 (-0.91%) - 09/17/21 Jefferies
- Alphabet price target raised to $3,325 from $3,150 at Jefferies
- 09/13/21
- Fly Intel: Top five analyst initiations
- 09/13/21 Goldman Sachs
- Alphabet Class A initiated with a Buy at Goldman Sachs
- 09/09/21 JPMorgan
- Netflix, Uber added as top U.S. Internet picks at JPMorgan
- $2,822.00 /
-21.41 (-0.75%) - 06/07/21 ThinkEquity
- Red Cat initiated with a Buy at ThinkEquity
- 09/15/21 Craig-Hallum
- Aspen Group price target lowered to $10 from $14 at Craig-Hallum
- 07/14/21 Canaccord
- Aspen Group price target lowered to $13 from $14 at Canaccord
- 06/24/21 Canaccord
- Aspen Group a good entry point following retreat from highs, says Canaccord
- 05/18/21 Roth Capital
- Aspen Group risk/reward 'highly favorable,' says Roth Capital
ASLN Aslan Pharmaceuticals - 09/27/21 Piper Sandler
- Piper buyers on Aslan weakness, thinks ASLAN-004 can be competitive
- 07/09/21 Jefferies
- Aslan Pharmaceuticals initiated with a Buy at Jefferies
- 05/11/21 Piper Sandler
- Aslan Pharmaceuticals price target lowered to $8 from $9 at Piper Sandler
- 03/17/21 H.C. Wainwright
- Aslan Pharmaceuticals price target raised to $8 from $5 at H.C. Wainwright
CAPR Capricor Therapeutics - 09/27/21 Stifel
- SeaSpine second spine company to preview softer Q3, says Stifel
- 09/27/21 BTIG
- SeaSpine price target lowered to $23 from $28 at BTIG
- 08/02/21 Piper Sandler
- SeaSpine sales upside more than offset increased opex, says Piper Sandler
- 05/25/21 Canaccord
- SeaSpine investors should add positions ahead of second-half, says Canaccord
- 01/21/21 Cantor Fitzgerald
- Cantor starts 'under the radar' iBio with Overweight, $3 target
- 01/21/21 Cantor Fitzgerald
- iBio initiated with an Overweight at Cantor Fitzgerald
- 11/18/20 Alliance Global Partners
- iBio price target lowered to $2 from $3.10 at Alliance Global Partners
- 05/19/21 Stifel
- Prime Mining initiated with a Buy at Stifel
- 09/27/21 GLJ Research
- JinkoSolar cut Q3 guidance with Friday's Jiangxi Jinko news, says GLJ Research
- 09/16/21 Roth Capital
- JinkoSolar price target lowered to $51 from $58 at Roth Capital
- 09/16/21 GLJ Research
- GLJ sees nearly 80% downside in JinkoSolar, cuts target to $10.70
- 08/13/21 GLJ Research
- JinkoSolar shipment into U.S. stopped by customs, says GLJ Research
- 09/27/21
- Fly Intel: Top five analyst downgrades
- 09/27/21 BTIG
- Lordstown Motors price target lowered to $10 from $20 at BTIG
- 09/26/21 Goldman Sachs
- Lordstown Motors downgraded to Sell from Neutral at Goldman Sachs
- 09/16/21 BofA
- BofA cuts Lordstown Motors to Underperform, halves price target to $5
- $3,372.13 /
-54.85 (-1.60%) - 09/27/21 Morgan Stanley
- Morgan Stanley cuts Amazon target to $4,100 on rising wage pressure
- 09/24/21 Morgan Stanley
- Vtex upgraded to Overweight from Equal Weight at Morgan Stanley
- 09/24/21 Oppenheimer
- Opco downgrades Cloudflare amid competition from Amazon, Microsoft
- 09/14/21 Evercore ISI
- Amazon price target raised to $4,700 from $4,200 at Evercore ISI
- $173.84 /
-2.065 (-1.17%) - 09/27/21
- Fly Intel: Top five analyst initiations
- 09/27/21 JPMorgan
- Airbnb initiated with a Neutral at JPMorgan
- 09/15/21 Tigress Financial
- Airbnb shares going to $206 in 12 months, says Tigress Financial
- 09/27/21 Raymond James
- Altice USA downgraded to Market Perform on strategic shift at Raymond James
- 09/27/21 Credit Suisse
- Credit Suisse downgrades Altice USA amid new investment strategy
- 09/27/21 Credit Suisse
- Altice USA downgraded to Neutral from Outperform at Credit Suisse
- 09/26/21 Goldman Sachs
- General Motors price target lowered to $59 from $62 at Goldman Sachs
- 09/24/21 Citi
- GM investor day could be 'significant positive catalyst,' says Citi
- 09/13/21 Barclays
- General Motors price target lowered to $68 from $71 at Barclays
- 08/09/21 Jefferies
- General Motors price target lowered to $53 from $68 at Jefferies
- 09/26/21 Goldman Sachs
- BorgWarner price target lowered to $47 from $48 at Goldman Sachs
- 09/20/21 Jefferies
- Lear downgraded to Hold amid tier 1 supplier ratings shake-up at Jefferies
- 09/20/21 Jefferies
- BorgWarner downgraded to Hold amid tier 1 supplier ratings shake-up at Jefferies
- 09/20/21 Jefferies
- BorgWarner downgraded to Hold from Buy at Jefferies
- 09/26/21 Goldman Sachs
- Gentex price target lowered to $30 from $32 at Goldman Sachs
- 09/20/21 Jefferies
- Visteon upgraded to Buy at Jefferies amid tier 1 supplier ratings shake-up
- 07/26/21 Seaport Global
- Gentex upgraded to Buy from Neutral at Seaport Global
- 07/26/21 B. Riley
- Gentex price target lowered to $41 from $45 at B. Riley
- 09/26/21 Goldman Sachs
- Lear price target lowered to $193 from $198 at Goldman Sachs
- 09/20/21
- Fly Intel: Top five analyst downgrades
- 09/26/21 Goldman Sachs
- Magna price target lowered to $102 from $105 at Goldman Sachs
- 09/23/21 Tudor Pickering
- Fisker initiated with a Buy at Tudor Pickering
- 09/16/21 BofA
- Fisker downgraded to Neutral at BofA amid 'fierce' competition in EV space
- 08/18/21 Credit Suisse
- Veoneer upgraded to Neutral from Underperform at Credit Suisse
- 09/26/21 Goldman Sachs
- Visteon price target lowered to $104 from $120 at Goldman Sachs
- 09/20/21 Jefferies
- Visteon upgraded to Buy from Hold at Jefferies
- 09/16/21
- Fly Intel: Top five analyst downgrades
- 09/26/21 Goldman Sachs
- Aptiv price target lowered to $174 from $176 at Goldman Sachs
- 09/20/21 Jefferies
- Aptiv price target lowered to $184 from $190 at Jefferies
- 08/06/21 Deutsche Bank
- Aptiv price target raised to $176 from $169 at Deutsche Bank
- 08/06/21 Barclays
- Aptiv price target raised to $174 from $164 at Barclays
- 09/26/21 Goldman Sachs
- Amphenol price target raised to $80 from $75 at Goldman Sachs
- 09/22/21 Jefferies
- Amphenol price target raised to $88 from $84 at Jefferies
- 08/03/21 Cowen
- Amphenol price target raised to $80 from $75 at Cowen
- 04/29/21 Citi
- Amphenol price target raised to $80 from $70 at Citi
INVZ Innoviz Technologies - 09/26/21 Goldman Sachs
- Innoviz Technologies price target lowered to $7 from $10 at Goldman Sachs
- 05/25/21 Berenberg
- Innoviz Technologies initiated with a Buy at Berenberg
- 05/19/21 Cantor Fitzgerald
- Innoviz Technologies initiated with an Overweight at Cantor Fitzgerald
- 05/19/21 Cantor Fitzgerald
- Innoviz Technologies initiated with an Overweight at Cantor Fitzgerald
- 09/26/21 Goldman Sachs
- Velodyne Lidar price target lowered to $7 from $9 at Goldman Sachs
- 07/20/21 Baird
- Baird downgrades Velodyne Lidar on 'further uncertainty' after CEO exit
- 07/20/21 Baird
- Velodyne Lidar downgraded to Neutral from Outperform at Baird
- 05/11/21 Needham
- Velodyne Lidar price target lowered to $15 from $20 at Needham
KEYS Keysight Technologies - 09/26/21 Goldman Sachs
- Keysight price target raised to $192 from $180 at Goldman Sachs
- 08/24/21 UBS
- Keysight Technologies price target raised to $192 from $170 at UBS
- 08/23/21 Deutsche Bank
- Keysight Technologies price target raised to $179 from $158 at Deutsche Bank
- 08/19/21 Baird
- Keysight Technologies price target raised to $175 from $155 at Baird
- $180.17 /
+12.65 (+7.55%) - 08/05/21
- Acceleron reports Q2 EPS ($1.05), consensus (88c)
- 07/28/21
- Acceleron sees Q2 REBLOZYL royalty revenue $25.6M vs. $22.4 last quarter
- 05/06/21
- Acceleron reports Q1 EPS (77c), consensus (81c)
- 08/05/21
- Velodyne Lidar sees FY21 revenue $77M-$94M, consensus $85.87M
- 08/05/21
- Velodyne Lidar reports Q2 adjusted EPS (18c), consensus (14c)
- 05/10/21
- Velodyne Lidar sees FY21 revenue $77M-$94M, consensus $93.76M
- 05/10/21
- Velodyne Lidar reports Q1 adjusted EPS (14c), consensus (12c)
- 08/05/21
- Vir Biotechnology reports Q2 EPS 46c, consensus (48c)
- 07/29/21
- Visteon reports Q2 adjusted EPS (32c), consensus 10c
- 04/29/21
- Visteon reports Q1 EPS 56c, consensus 24c
- $792.36 /
+17.74 (+2.29%) - 07/26/21
- Tesla reports Q2 non-GAAP EPS $1.45, consensus 96c
- 07/26/21
- Notable companies reporting after market close
- 04/26/21
- Tesla reports Q1 non-GAAP EPS 93c, consensus 79c
- 09/27/21
- SeaSpine sees Q3 revenue up mid-single digit, withdraws FY21 guidance
- 08/02/21
- SeaSpine sees FY21 revenue $201M-$205M, consensus $198.73M
- 08/02/21
- SeaSpine reports Q2 EPS (16c), consensus (32c)
- 08/02/21
- SeaSpine reports Q2 EPS (16c), consensus (32c)
- 08/11/21
- Lordstown Motors reports Q2 EPS (61c), consensus (46c)
- 08/11/21
- Notable companies reporting after market close
- 05/24/21
- Lordstown Motors reports Q1 EPS (72c), consensus (28c)
- 05/24/21
- Notable companies reporting after market close
- 09/20/21
- Red Cat reports Q1 EPS (5c) vs. (2c) last year
- 09/27/21
- Puyi reports 2021 EPS (RMB0.770) vs. (RMB0.546) last year
- 09/27/21
- Prime Mining reports Q1 EPS (C$0.04) vs. (C$0.04) last year
- 08/16/21
- Prime Mining reports Q4 EPS (C$0.04) vs. (C$0.12) last year
- 08/04/21
- MGM Resorts reports Q2 adjusted EPS (13c), consensus (44c)
- 08/04/21
- IAC reports Q2 EPS $2.02 vs. ($1.13) last year
- 08/04/21
- Notable companies reporting after market close
- 04/28/21
- MGM Resorts reports Q1 adjusted EPS (68c), consensus (85c)
- 08/06/21
- Magna cuts FY21 revenue view to $38B-$39.5B from $40B-$41.6B, consensus $40.99B
- 08/06/21
- Magna reports Q2 adjusted EPS $1.40, consensus $1.47
- 05/06/21
- Magna raises FY21 revenue view to $40.2B-$41.8B from $40B-$41.6B
- 05/06/21
- Magna reports Q1 adjusted EPS $1.86, consensus $1.57
- 08/06/21
- Lear cuts FY21 revenue view to $19.7B-$20.5B from $20.35B-$21.15B
- 08/06/21
- Lear reports Q2 adjusted EPS $2.45, consensus $2.68
- 05/07/21
- Lear raises FY21 revenue view to $20.35B-$21.15B from $19.8B-$20.8B
- 05/07/21
- Lear reports Q1 adjusted EPS $3.73, consensus $2.95
KEYS Keysight Technologies - 08/18/21
- Keysight Technologies sees Q4 EPS $1.59-$1.65, consensus $1.59
- 08/18/21
- Keysight Technologies reports Q3 EPS $1.54, consensus $1.44
- 05/19/21
- Keysight Technologies sees Q3 adjusted EPS $1.39-$1.45, consensus $1.38
- 05/19/21
- Keysight Technologies reports Q2 adjusted EPS $1.44, consensus $1.34
- 09/27/21
- JinkoSolar sees Jiangxi Jinko revenue for 9 months end Sep. 30 at RMB23.6B-23.8B
- 09/15/21
- JinkoSolar reports Q2 EPS 22c, consensus (16c)
- 09/14/21
- Notable companies reporting before tomorrow's open
- 06/25/21
- JinkoSolar sees Q2 revenue $1.2B-$1.25B, consensus $1.4B
- 09/27/21
- iBio reports 2021 EPS (12c) vs. (61c) last year
- 05/17/21
- iBio reports Q3 EPS (4c) vs. (6c) last year
- 07/28/21
- Humana backs FY21 adjusted EPS view $21.25-$21.75, consensus $21.70
- 07/28/21
- Humana reports Q2 adjusted EPS $6.89, consensus $6.82
- 07/27/21
- Notable companies reporting before tomorrow's open
- 07/28/21
- GSK backs 2021 adjusted EPS to decline by mid-to-high single-digit percentage
- 07/28/21
- GlaxoSmithKline reports Q2 adjusted EPS 28.1p vs. 19.2p last year
- 04/28/21
- GlaxoSmithKline reconfirms guidance range for 2021
- 04/28/21
- GlaxoSmithKline reports Q1 adjusted EPS 22.9p vs. 37.7p a year ago
- $2,827.67 /
-26.03 (-0.91%) - 07/27/21
- Alphabet reports Q2 EPS $27.26, consensus $19.21
- 06/08/21
- Cubic and NXP Seminconductors launch SmarTrip on Google Pay
- 05/25/21
- Esports Technologies to launch Esports games app on Google Play Store
- 07/23/21
- Gentex sees 2H21 revenue $970M-1.07B
- 07/23/21
- Gentex reports Q2 EPS 36c, consensus 45c
- 04/23/21
- Gentex sees 2022 revenue 8%-13% higher than 2021 revenue, consensus $2.18B
- 04/23/21
- Gentex sees 2021 revenue $1.94B-$2.02B, consensus $2B
- 08/04/21
- General Motors reports Q2 GM North America EBIT-adjusted of $2.9B
- 08/04/21
- General Motors raises FY21 adjusted EPS view to $5.40-$6.40 from $4.50-$5.25
- 08/04/21
- General Motors reports Q2 adjusted EPS $1.97, consensus $1.34
- 08/03/21
- Notable companies reporting before tomorrow's open
- $351.45 /
-1.685 (-0.48%) - 07/28/21
- Facebook says Q3, Q4 revenue growth rates to 'decelerate significantly'
- 07/28/21
- Facebook reports Q2 EPS $3.61, consensus $3.02
- 07/28/21
- Notable companies reporting after market close
- 04/28/21
- Facebook sees Q2 year-over-year revenue growth stable or to modestly accelerate
- 07/28/21
- Deutsche Bank reports Q2 net profit EUR828M vs. EUR61M last year
- 04/28/21
- Deutsche Bank reports Q1 net profit EUR1B vs. EUR66M last year
- 07/29/21
- Credit Suisse reports Q2 net revenue CHF 5.1B vs. CHF 6.19B last year
- 04/22/21
- Credit Suisse reports Q1 net revenue CHF 7.57B vs. CHF 5.78B last year
- 04/06/21
- Credit Suisse sees Q1 loss of CHF 900M, CHF $4.4B charge for hedge fund
- 07/22/21
- Blackstone reports Q2 distributable EPS 82c, consensus 77c
- 07/21/21
- Notable companies reporting before tomorrow's open
- 04/22/21
- Blackstone reports Q1 distributable EPS 96c, consensus 76c
- 08/04/21
- BorgWarner raises FY21 adjusted EPS view to $4.15-$4.40 from $4.00-$4.35
- 08/04/21
- BorgWarner reports Q2 adjusted EPS $1.08, consensus 81c
- 07/22/21
- Biogen raises FY21 revenue view to $10.65B-$10.85B from $10.45B-$10.75B
- 07/22/21
- Biogen reports Q2 EPS $5.68, consensus $4.55
- 05/25/21
- Vinco Ventures reports Q1 EPS ($3.28) vs. 13c last year
- 07/28/21
- Altice USA reports Q2 EPS 43c, consensus 47c
- 04/28/21
- Altice USA still sees revenue growth for FY21, consensus $10.11B
- 04/28/21
- Altice USA reports Q1 EPS 58c, consensus 31c
- 09/14/21
- Aspen Group reports Q1 EPS (3c), consensus (5c)
- 07/13/21
- Aspen Group sees FY22 EPS (18c)-(12c), consensus 4c
- 07/13/21
- Aspen Group reports Q4 EPS (9c), consensus (5c)
- 06/23/21
- Aspen Group reports Q4 revenue $19.1M, consensus $18.52M
ASLN Aslan Pharmaceuticals - 08/06/21
- Aslan Pharmaceuticals reports Q2 EPS (8c), consensus (11c)
- 05/11/21
- Aslan Pharmaceuticals reports Q1 EPS (2c), one est. (11c)
- 04/22/21
- Aslan Pharmaceuticals reports Q4 EPS (3c) vs. (18c) last year
- 08/05/21
- Aptiv raises FY21 EPS view to $3.63-$3.87 from $3.35-$3.85, consensus $3.74
- 08/05/21
- Aptiv reports Q2 EPS 60c, consensus 69c
- 05/06/21
- Aptiv backs FY21 adjusted EPS view $3.35-$3.85, consensus $3.67
- 05/06/21
- Aptiv reports Q1 ex-items EPS $1.06, consensus 78c
- 07/28/21
- Amphenol sees Q3 EPS 60c-62c, consensus 59c
- 07/28/21
- Amphenol reports Q2 EPS 61c, consensus 55c
- 04/28/21
- Amphenol sees Q2 EPS 53c-55c, consensus 52c
- 04/28/21
- Amphenol reports Q1 EPS 53c, consensus 47c
- $3,372.13 /
-54.85 (-1.60%) - 07/29/21
- Amazon sees Q3 revenue $106B-$112B, consensus $118.62B
- 07/29/21
- Amazon reports Q2 EPS $15.12, consensus $12.22
- 07/29/21
- Notable companies reporting after market close
- 04/29/21
- Amazon.com sees Q2 revenue $110B-$116B, consensus $108.68B
- $173.84 /
-2.065 (-1.17%) - 08/12/21
- Airbnb reports Q2 EPS (11c), consensus (48c)
- 08/12/21
- Notable companies reporting after market close
- 05/13/21
- Airbnb sees Q2 revenue to be 'significantly higher than that of Q2 2020'
- 05/13/21
- Airbnb reports Q1 EPS ($1.95), consensus ($1.19)
- 07/30/21
- Musk sides with Epic, says Apple fees 'de facto global tax' on internet
- 07/27/21
- Apple reports Q3 EPS $1.30, consensus $1.00
- 07/27/21
- Notable companies reporting after market close
- 05/01/21
- Berkshire Hathaway reports Q1 EPS $5.09, consensus $2.53
|